Lifevantage Corp Financials
This page shows Lifevantage Corp (LFVN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
LifeVantage’s model is a high-gross-margin business where profit recovery depends more on SG&A absorption than heavy reinvestment.
Versus the prior year, net income rose to$9.8M while operating cash flow stayed near$11.9M , so the earnings rebound was real but not fully cash-released. The likely absorber was inventory build: inventory expanded from$15.1M to$20.7M , meaning more of the recovery was parked in working capital than collected immediately.
The key operating change happened below gross profit, not at the product level: gross margin held around
This remains a cash-generative, low-capex model: free cash flow reached
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Lifevantage Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Lifevantage Corp has an operating margin of 5.3%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 52/100, indicating healthy but not exceptional operating efficiency. This is up from 2.2% the prior year.
Lifevantage Corp's revenue grew 14.2% year-over-year to $228.5M, a solid pace of expansion. This earns a growth score of 44/100.
Lifevantage Corp has a moderate D/E ratio of 1.08. This balance of debt and equity financing earns a leverage score of 45/100.
Lifevantage Corp's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.
Lifevantage Corp has a free cash flow margin of 4.6%, earning a moderate score of 44/100. The company generates positive cash flow after capital investments, but with room for improvement.
Lifevantage Corp earns a strong 28.3% return on equity (ROE), meaning it generates $28 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 79/100. This is up from 11.3% the prior year.
Lifevantage Corp scores 3.36, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Lifevantage Corp passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Lifevantage Corp generates $1.21 in operating cash flow ($11.9M OCF vs $9.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Lifevantage Corp generated $228.5M in revenue in fiscal year 2025. This represents an increase of 14.2% from the prior year.
Lifevantage Corp's EBITDA was $15.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 94.0% from the prior year.
Lifevantage Corp reported $9.8M in net income in fiscal year 2025. This represents an increase of 233.8% from the prior year.
Lifevantage Corp earned $0.75 per diluted share (EPS) in fiscal year 2025. This represents an increase of 226.1% from the prior year.
Cash & Balance Sheet
Lifevantage Corp generated $10.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 5.6% from the prior year.
Lifevantage Corp held $20.2M in cash against $0 in long-term debt as of fiscal year 2025.
Lifevantage Corp paid $0.17 per share in dividends in fiscal year 2025. This represents a decrease of 69.7% from the prior year.
Lifevantage Corp had 12M shares outstanding in fiscal year 2025. This represents a decrease of 0.6% from the prior year.
Margins & Returns
Lifevantage Corp's gross margin was 80.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.1 percentage points from the prior year.
Lifevantage Corp's operating margin was 5.3% in fiscal year 2025, reflecting core business profitability. This is up 3.2 percentage points from the prior year.
Lifevantage Corp's net profit margin was 4.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.8 percentage points from the prior year.
Lifevantage Corp's ROE was 28.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 17.0 percentage points from the prior year.
Capital Allocation
Lifevantage Corp invested $1.4M in research and development in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Lifevantage Corp spent $3.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 51.1% from the prior year.
Lifevantage Corp invested $1.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 38.9% from the prior year.
LFVN Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $43.7M-10.7% | $48.9M+2.9% | $47.6M-13.7% | $55.1M-5.7% | $58.4M-13.8% | $67.8M+43.5% | $47.2M-3.5% | $48.9M |
| Cost of Revenue | $9.2M-27.9% | $12.7M+30.5% | $9.7M-11.9% | $11.1M-0.4% | $11.1M-15.8% | $13.2M+39.0% | $9.5M-5.3% | $10.0M |
| Gross Profit | $34.5M-4.6% | $36.2M-4.2% | $37.8M-14.2% | $44.0M-6.9% | $47.3M-13.3% | $54.6M+44.7% | $37.7M-3.0% | $38.9M |
| R&D Expenses | $200K0.0% | $200K-33.3% | $300K-40.0% | $500K+25.0% | $400K+100.0% | $200K-33.3% | $300K+50.0% | $200K |
| SG&A Expenses | $13.9M-12.4% | $15.8M+6.6% | $14.9M-20.5% | $18.7M+9.5% | $17.1M-8.3% | $18.6M+25.4% | $14.8M+5.9% | $14.0M |
| Operating Income | $1.7M+244.6% | $487K-78.5% | $2.3M+5.6% | $2.1M-47.0% | $4.1M+18.2% | $3.4M+33.4% | $2.6M-11.7% | $2.9M |
| Interest Expense | $11K | N/A | N/A | N/A | N/A | N/A | N/A | -$782K |
| Income Tax | $294K+49.2% | $197K+129.1% | $86K-80.3% | $437K-38.5% | $710K+31.7% | $539K-28.3% | $752K-46.6% | $1.4M |
| Net Income | $1.4M+393.5% | $276K-87.2% | $2.2M+10.0% | $2.0M-43.5% | $3.5M+36.1% | $2.5M+39.6% | $1.8M+39.9% | $1.3M |
| EPS (Diluted) | $0.11+450.0% | $0.02-88.2% | $0.17 | N/A | $0.26+36.8% | $0.19+35.7% | $0.14 | N/A |
LFVN Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $62.1M+1.6% | $61.2M-0.7% | $61.6M-14.4% | $72.0M-6.8% | $77.2M+12.7% | $68.5M+11.5% | $61.5M+1.9% | $60.3M |
| Current Assets | $39.3M+2.0% | $38.6M-14.4% | $45.0M-11.5% | $50.9M-6.0% | $54.1M+18.2% | $45.8M+18.0% | $38.8M+3.1% | $37.6M |
| Cash & Equivalents | $12.5M+22.6% | $10.2M-22.2% | $13.1M-35.2% | $20.2M-10.1% | $22.5M+4.0% | $21.6M+48.0% | $14.6M-13.6% | $16.9M |
| Inventory | $18.4M-3.1% | $19.0M-7.8% | $20.6M-0.4% | $20.7M-7.0% | $22.2M+27.2% | $17.5M+3.3% | $16.9M+12.3% | $15.1M |
| Accounts Receivable | $2.4M+7.3% | $2.3M-7.0% | $2.4M-26.4% | $3.3M+1.7% | $3.2M+55.2% | $2.1M-29.7% | $3.0M+0.6% | $2.9M |
| Goodwill | $472K0.0% | $472K | N/A | $0 | N/A | N/A | N/A | N/A |
| Total Liabilities | $28.8M+2.2% | $28.2M-0.8% | $28.4M-23.8% | $37.3M-13.7% | $43.2M+11.9% | $38.6M+14.4% | $33.8M-1.6% | $34.3M |
| Current Liabilities | $20.1M+5.7% | $19.0M+1.0% | $18.8M-30.8% | $27.2M-16.5% | $32.6M+18.3% | $27.5M+24.8% | $22.1M-1.1% | $22.3M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $33.3M+1.1% | $33.0M-0.5% | $33.2M-4.3% | $34.6M+1.9% | $34.0M+13.8% | $29.9M+7.9% | $27.7M+6.6% | $26.0M |
| Retained Earnings | -$103.7M-0.2% | -$103.4M-0.3% | -$103.1M+1.0% | -$104.1M-0.6% | -$103.5M+2.8% | -$106.5M+1.9% | -$108.5M+0.2% | -$108.7M |
LFVN Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.0M+78.7% | $2.8M+221.1% | -$2.3M-322.9% | $1.0M-53.6% | $2.2M-75.8% | $9.2M+1677.9% | -$583K-122.6% | $2.6M |
| Capital Expenditures | $1.0M-6.7% | $1.1M+146.9% | $439K+120.6% | $199K-39.9% | $331K-32.7% | $492K+41.0% | $349K+25.5% | $278K |
| Free Cash Flow | $4.0M+133.0% | $1.7M+162.2% | -$2.7M-428.6% | $835K-56.0% | $1.9M-78.2% | $8.7M+1034.2% | -$932K-140.5% | $2.3M |
| Investing Cash Flow | -$1.0M+79.1% | -$4.8M-999.5% | -$439K-120.6% | -$199K+39.9% | -$331K+32.7% | -$492K-42.6% | -$345K-24.1% | -$278K |
| Financing Cash Flow | -$1.6M-116.5% | -$738K+82.8% | -$4.3M-32.5% | -$3.2M-187.8% | -$1.1M+19.5% | -$1.4M+23.4% | -$1.8M+33.3% | -$2.7M |
| Dividends Paid | $573K-0.3% | $575K+0.7% | $571K+1.6% | $562K+11.7% | $503K+0.2% | $502K+0.4% | $500K-0.6% | $503K |
| Share Buybacks | $1.0M+100700.0% | -$1K-100.2% | $578K-71.6% | $2.0M | $0 | $0-100.0% | $1.1M-39.2% | $1.8M |
LFVN Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 79.0%+5.0pp | 74.0%-5.5pp | 79.5%-0.4pp | 79.9%-1.1pp | 81.0%+0.4pp | 80.5%+0.6pp | 79.9%+0.4pp | 79.5% |
| Operating Margin | 3.8%+2.8pp | 1.0%-3.8pp | 4.8%+0.9pp | 3.9%-3.0pp | 6.9%+1.9pp | 5.1%-0.4pp | 5.4%-0.5pp | 5.9% |
| Net Margin | 3.1%+2.6pp | 0.6%-4.0pp | 4.5%+1.0pp | 3.5%-2.4pp | 5.9%+2.2pp | 3.8%-0.1pp | 3.9%+1.2pp | 2.7% |
| Return on Equity | 4.1%+3.3pp | 0.8%-5.7pp | 6.5%+0.8pp | 5.7%-4.5pp | 10.2%+1.7pp | 8.5%+1.9pp | 6.6%+1.6pp | 5.0% |
| Return on Assets | 2.2%+1.7pp | 0.4%-3.1pp | 3.5%+0.8pp | 2.7%-1.8pp | 4.5%+0.8pp | 3.7%+0.7pp | 3.0%+0.8pp | 2.2% |
| Current Ratio | 1.96-0.1 | 2.03-0.4 | 2.39+0.5 | 1.87+0.2 | 1.660.0 | 1.66-0.1 | 1.76+0.1 | 1.69 |
| Debt-to-Equity | 0.860.0 | 0.850.0 | 0.86-0.2 | 1.08-0.2 | 1.27-0.0 | 1.29+0.1 | 1.22-0.1 | 1.32 |
| FCF Margin | 9.1%+5.6pp | 3.5%+9.3pp | -5.8%-7.3pp | 1.5%-1.7pp | 3.3%-9.6pp | 12.8%+14.8pp | -2.0%-6.7pp | 4.7% |
Similar Companies
Frequently Asked Questions
What is Lifevantage Corp's annual revenue?
Lifevantage Corp (LFVN) reported $228.5M in total revenue for fiscal year 2025. This represents a 14.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Lifevantage Corp's revenue growing?
Lifevantage Corp (LFVN) revenue grew by 14.2% year-over-year, from $200.2M to $228.5M in fiscal year 2025.
Is Lifevantage Corp profitable?
Yes, Lifevantage Corp (LFVN) reported a net income of $9.8M in fiscal year 2025, with a net profit margin of 4.3%.
What is Lifevantage Corp's EBITDA?
Lifevantage Corp (LFVN) had EBITDA of $15.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Lifevantage Corp's gross margin?
Lifevantage Corp (LFVN) had a gross margin of 80.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Lifevantage Corp's operating margin?
Lifevantage Corp (LFVN) had an operating margin of 5.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Lifevantage Corp's net profit margin?
Lifevantage Corp (LFVN) had a net profit margin of 4.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Does Lifevantage Corp pay dividends?
Yes, Lifevantage Corp (LFVN) paid $0.17 per share in dividends during fiscal year 2025.
What is Lifevantage Corp's return on equity (ROE)?
Lifevantage Corp (LFVN) has a return on equity of 28.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Lifevantage Corp's free cash flow?
Lifevantage Corp (LFVN) generated $10.5M in free cash flow during fiscal year 2025. This represents a 5.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Lifevantage Corp's operating cash flow?
Lifevantage Corp (LFVN) generated $11.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Lifevantage Corp's total assets?
Lifevantage Corp (LFVN) had $72.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Lifevantage Corp's capital expenditures?
Lifevantage Corp (LFVN) invested $1.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Lifevantage Corp spend on research and development?
Lifevantage Corp (LFVN) invested $1.4M in research and development during fiscal year 2025.
What is Lifevantage Corp's current ratio?
Lifevantage Corp (LFVN) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.
What is Lifevantage Corp's debt-to-equity ratio?
Lifevantage Corp (LFVN) had a debt-to-equity ratio of 1.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Lifevantage Corp's return on assets (ROA)?
Lifevantage Corp (LFVN) had a return on assets of 13.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Lifevantage Corp's Altman Z-Score?
Lifevantage Corp (LFVN) has an Altman Z-Score of 3.36, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Lifevantage Corp's Piotroski F-Score?
Lifevantage Corp (LFVN) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Lifevantage Corp's earnings high quality?
Lifevantage Corp (LFVN) has an earnings quality ratio of 1.21x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Lifevantage Corp?
Lifevantage Corp (LFVN) scores 53 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.